MMIT has released a case report detailing how its MMIT Analytics platform helped one healthcare services company save time and resources when communicating with providers. Their platform allowed them to change course from asking providers to contact payers for patient coverage […]
Opinion: Build Back Better would set back medical science
Xavier Becerra testifies during a Senate Finance Committee hearing on his nomination to be secretary of Health and Human Services last year. File photo Democrats are hoping to include a major overhaul of Medicare prescription drug pricing in their Build Back Better legislation. The proposal would […]
STAT Health Tech: Healthcare Mergers and Acquisitions on the Rise
Several healthcare and biotech mergers and acquisitions (M&A) have been announced in recent months, according to the latest STAT Health Tech newsletter by STAT News. In the newsletter, authors Casey Ross and Katie Palmer discuss Withings’ acquisition of Impeto Health, Speak2Family’s acquisition […]
IBM Makes Another Attempt to Sell Watson Health
IBM is once again trying to sell IBM Watson Health with aims to make more than $1 billion. This comes after a first attempt to sell the division in late 2021 due to them deeming it unprofitable. Bids were closed as of January 4th, and the winner will likely be announced later this month. Alongside […]
Draft Ruling from CMS Suggests Narrow Coverage for Aduhelm
The Centers for Medicare & Medicaid Services (CMS) have released a draft ruling indicating it will only cover Biogen’s Alzheimer’s drug Aduhelm for patients in clinical trials. This ruling will have a stark financial impact on Biogen if it becomes final guidance, as older individuals, the […]
Upcoming Webinar: Getting Real with Real-World Evidence
Fierce Pharma and Databricks are hosting a webinar at 12 pm ET / 9 am PT, on Thursday, January 27th, 2022. The webinar will focus on the challenges surrounding real-world evidence (RWE) in the biopharma industry. In addition, ways in which RWE can be leveraged to open new opportunities will be […]
2022 Dealmakers’ Intentions Survey Released
Syneos Health Consulting has released the results of its 2022 Dealmakers’ Intentions Survey. The survey’s finding indicated that IPO markets and venture financing will benefit small companies over the upcoming year. The report predicts that the access to extra capital will allow smaller firms to […]
Amgen and Arrakis Therapeutics Announce Partnership to Develop RNA-targeting Oral Drugs
The biotech startup Arrakis Therapeutics has partnered with Amgen in a research collaboration to develop oral drugs that target disease-related RNA. Arrakis will be payed $75 million for five initial drug discovery options, with billions of dollars on the table if the programs are successful. Amgen […]
Pfizer Shifts to Virtual Meetings and Cuts Sales Staff
Pfizer will lay off sales staff as they pivot towards virtual sales meetings with providers to adjust to changing provider preferences. The company, which is expected to report 2021 revenue of over $80 billion, has not announced the amount of employees they will be laying off later this […]
Market Access Speed Makes the Differences for Pharma
Advances in science and legislative changes have accelerated drug discovery and approval in recent years. However, payers eye these drugs with increased skepticism due to ballooning healthcare costs. Therefore, pharma companies must consider market access and commercialization earlier in the […]
Pfizer, GSK and Teva lead 2022’s round of January drug price hikes: GoodRx
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx fkansteiner Tue, 01/04/2022 - 11:30 Read the source article at Pharma News 2022-01-04 16:13:23 […]
Opinion: Build Back Better would set back medical science
Xavier Becerra testifies during a Senate Finance Committee hearing on his nomination to be secretary of Health and Human Services last year. Democrats are hoping to include a major overhaul of Medicare prescription drug pricing in their Build Back Better legislation. The proposal would allow the […]
United States: 2022 Congressional Outlook And Top 10 Federal Health Policy Issues To Watch – Holland & Knight
As Congress reconvenes, it faces a packed agenda in a legislative year that will be shortened by the upcoming midterm elections and remains buffeted by the persistent coronavirus pandemic. The list of healthcare priorities is notably lengthy, and how much of this crowded agenda will move forward […]
Webinar: Getting real with real-world evidence: A discussion on building successful programs
The BioPharma industry has invested heavily in RWE programs and early adopters have seen promise in areas such as label expansion, safety studies, and clinical trial design. However, most organizations still wrestle with challenges like: - How do we integrate large volumes of real-world data, […]
Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022
Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, as well as consumer health products, today announced that its Board of Directors has appointed Alessandro Maselli, […]
Tools4Patient Announces Name Change to Cognivia & Expands Board of Directors
MONT-SAINT-GUIBERT, Belgium, Cognivia today announced a new name for the company formerly known as Tools4Patient, which provides clinical trials solutions based on AI / ML that account for individual patient personality traits, beliefs and perceptions. The transition to Cognivia more closely […]
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States
NEW BRUNSWICK, N.J. , Jan. 6, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson & Johnson COVID-19 vaccine […]
Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma Report also examines key therapeutic development areas to watch including mRNA, CRISPR, AI-driven drug discovery and more LONDON, Jan. 10, 2022 […]
Trendspotting: Decentralized Trials Maintain Momentum, Additional Remote Solutions, AI and Reducing Bias
Trendspotting: Decentralized Trials Maintain Momentum, Additional Remote Solutions, AI and Reducing Bias January 10, 2022 | We spoke with clinical research leaders to gain insights into expectations for the coming year. We heard predictions for a return to some of the pre-pandemic normalcy in the […]
Robert Califf is a fervent believer in data. At the FDA, will that be enough?
Matt's Take Robert Califf is a fervent believer in data. At the FDA, will that be enough? By Matthew Herper Jan. 5, 2022 Reprints Robert Califf testifying last month before a Senate hearing on his nomination to be FDA commissioner. Manuel Balce Ceneta/AP A t his confirmation hearing last month to […]
eClinical Solutions Market is Going To Boom | Oracle, BioClinica, ERT Clinical
Advertising Driven Press Release Distribution Latest business intelligence report released on Global eClinical Solutions Market, covers different industry elements and growth inclinations that helps in predicting market forecast. The report allows complete assessment of current and future scenario […]
Cancer Patients Save Money on Medication Due to ‘Skinny Labeling’
A new study finds that applying a ‘skinny label’ to the generic cancer drug Gleevec made the medicine available for more patients at a cheaper cost. Skinny labeling is the practice of getting approval for a generic for a specific purpose instead of the range of uses it is patented for. This allows […]
Insights on the Preclinical CRO Global Market to 2026 – Featuring Atuka, Emergo and ICON Among Others
Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Research Report by Services, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global Preclinical CRO Market size was estimated at USD […]
Healthcare Consulting Services Market worth $41.2 billion by 2026 – Exclusive Report by MarketsandMarkets™
CHICAGO , Jan. 7, According to the new market research report " Healthcare Consulting Services Market by Type of Service (Digital Health, IT, Operations, Strategy, Financial, HR & Talent), End User (Government Bodies, Healthcare Providers, Pharmaceutical & Biotechnology Companies), and […]
Solving the Drug Pricing Conundrum
AJ Loiacono, CEO of Capital Rx, which doubles as pharmacy benefit manager (PBM) and health tech firm, dives into his inspiration for entering the PBM arena, the company’s formula for providing more transparency into drug pricing and the importance of simplifying complex administrative and workflow […]
Metro Denver Pain
Metro Denver Pain Metro Denver Pain Content The outgoing Trump administration declared that the “prescription opioid epidemic” is over, however the whole variety of drug overdose deaths greater than doubled since 2011. Over the past twenty years, media outlets ran sensational stories about young […]
Global Medical Device Contract Research Organization (CRO) Market Analysis Report 2021 by Phase (Preclinical, Clinical), & Service (Regulatory/Medical Affairs, Clinical Monitoring) – ResearchAndMarkets.com | Business
DUBLIN--(BUSINESS WIRE)--Jan 6, 2022-- The "Medical Device Contract Research Organization Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), by Service (Regulatory/Medical Affairs, Clinical Monitoring), by Region (APAC, North America), and Segment Forecasts, 2021-2028" […]
Pharmacists are a Vital Part of the Value Chain
That would be a marked change from the past year, which prioritized rhetoric and politics over an evidence-based understanding of the health care value chain and the challenges patients face at the pharmacy counter. At the National Pharmaceutical Council, this year we intend to play a significant […]
Pharmacovigilance Market Size Forecast 2020-2028 by Global Industry Trends, Revenue, and Business Prospect by Sanofi, Accenture, Cognizant Technology Solutions, Clinquest Group B.V.
Pharmacovigilance Market Size Forecast 2020-2028 by Global Industry Trends, Revenue, and Business Prospect by Sanofi, Accenture, Cognizant Technology Solutions, Clinquest Group B.V. The Global Pharmacovigilance market report covers deep insights of various vital aspects of the market. Moreover, in […]
The Big-Ticket Drugs That Have Higher Prices In 2022
Source: Axios, by Bob Herman Drug companies raised the prices on hundreds of medications on Jan. 1, with most prices up 5% to 6% on average. Why it matters: The start of the new year is the most popular time for drug companies to hike prices, and even though high drug prices remain one of the […]
